Reuters logo
BRIEF-Acelrx Pharmaceuticals posts Q3 loss of $0.28 per share
November 9, 2017 / 10:03 PM / a month ago

BRIEF-Acelrx Pharmaceuticals posts Q3 loss of $0.28 per share

Nov 9 (Reuters) - Acelrx Pharmaceuticals Inc

* Acelrx pharmaceuticals reports third quarter 2017 financial results

* Q3 loss per share $0.28

* Q3 revenue $1.5 million

* Q3 revenue view $2.2 million -- Thomson Reuters I/B/E/S

* Q3 earnings per share view $-0.27 -- Thomson Reuters I/B/E/S

* Acelrx pharmaceuticals - $67.9 million of cash and cash equivalents at Sseptember 30, 2017​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below